Literature DB >> 11123086

Vasculitis of the central nervous system.

P M Moore1.   

Abstract

Central nervous system (CNS) vasculitis occurs in a variety of clinical settings. Some exhibit a distinct age preference; others a tissue tropism. Most frequently encountered are giant cell arteritis (temporal arteritis) and vasculitis secondary to infections. The CNS may be involved in the systemic vasculitides, and neurologic abnormalities occasionally appear as a presenting manifestation of disease. Isolated angiitis of the CNS, a rare form of vasculitis restricted to the CNS, must be distinguished from other causes of CNS inflammation and from noninflammatory vascular disease. We are learning a great deal about the cellular mechanisms of vascular inflammation in the brain. Some manifestations of the clinical disease result from histologic features of the infiltrate and the size of affected vessel. However, the local consequences of inflammation such as increased coagulation and altered vasomotor tone, as well as the systemic consequences such as activation of the central noradrenergic systems, trigeminovascular system, and hypothalamic pituitary adrenal axis contribute to both pathogenesis of disease and recovery. Two central issues that confront us now are improving the accuracy of the diagnosis (including identifying any underlying infectious causes) and limiting the long-term damage both from disease and its therapies.

Entities:  

Mesh:

Year:  2000        PMID: 11123086     DOI: 10.1007/s11926-000-0036-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  56 in total

1.  Histopathologic features of cerebral vasculitis associated with mycobacterium tuberculosis.

Authors:  F J Blanco García; M Sánchez Blas; M Freire González
Journal:  Arthritis Rheum       Date:  1999-02

Review 2.  Expression of adhesion molecules and histocompatibility antigens at the blood-brain barrier.

Authors:  H Lassmann; K Rössler; F Zimprich; K Vass
Journal:  Brain Pathol       Date:  1991-01       Impact factor: 6.508

3.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

4.  Diagnosis of microvasculopathy in CNS vasculitis: value of perfusion and diffusion imaging.

Authors:  W T Yuh; T Ueda; J E Maley; J P Quets; M White; P Y Hahn; S Otake
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

5.  Isolated angiitis of the CNS presenting as subarachnoid haemorrhage.

Authors:  R Kumar; E F Wijdicks; R D Brown; J E Parisi; C A Hammond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

6.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.

Authors:  L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  1999-03

7.  Idiopathic granulomatous angiitis of the CNS manifesting as diffuse white matter disease.

Authors:  P F Finelli; H C Onyiuke; D F Uphoff
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

8.  Isolated central nervous system vasculitis associated with hepatitis C infection.

Authors:  T M Dawson; G Starkebaum
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

9.  Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system.

Authors:  L H Calabrese; L A Gragg; A J Furlan
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666

10.  Angiographically defined primary angiitis of the CNS: is it really benign?

Authors:  A R Woolfenden; D C Tong; M P Marks; A O Ali; G W Albers
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

View more
  7 in total

1.  Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus.

Authors:  Amitinder Kaur; Hannah B Sanford; Deirdre Garry; Sabine Lang; Sherry A Klumpp; Daisuke Watanabe; Roderick T Bronson; Jeffrey D Lifson; Margherita Rosati; George N Pavlakis; Barbara K Felber; David M Knipe; Ronald C Desrosiers
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

Review 2.  Lupus vasculitis: differential diagnosis with antiphospholipid syndrome.

Authors:  Theo Dov Golan
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

3.  Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life.

Authors:  Tobias Back; Steffi Grünig; Yaroslav Winter; Ulf Bodechtel; Kersten Guthke; Diana Khati; Rüdiger von Kummer
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

4.  Systemic Lupus Erythematosus Vasculitis: A Current Therapeutic Overview.

Authors:  Elias Toubi; Aharon Kessel; Ellen Bamberger; Theo Dov Golan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

5.  Primary angiitis of the CNS with pure spinal cord involvement: a case report.

Authors:  Chantima Goertz; Christiane Wegner; Wolfgang Brück; Peter Berlit
Journal:  J Neurol       Date:  2010-06-18       Impact factor: 4.849

6.  An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients.

Authors:  Carlo Salvarani; Robert D Brown; Teresa Christianson; Dylan V Miller; Caterina Giannini; John Huston; Gene G Hunder
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

7.  Primary central nervous system vasculitis preceded by granulomatous hypophysitis: Case report with a review of the literature.

Authors:  Meng Huang; William J Steele; David S Baskin
Journal:  Surg Neurol Int       Date:  2015-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.